Company intelligence / Profile preview

NOVIGO Pharma Inc.

Fukuoka-shi Nishi-ku, Fukuoka, Japannovigopharma.co.jp ↗

Ownership: Private
Employees: ~7
Development stage: Other

Overview

NOVIGO Pharma is a Kyushu University spin-out developing next-generation drug delivery systems using proprietary lipid nanoparticle technology. The company focuses on transdermal absorption, intracellular delivery, and extracellular vesicle-based approaches. As of mid 2025, the company remains at the formulation development stage with plans to enter preclinical trials in late 2025. It has completed Series A funding rounds supported by NEDO projects.

Modalities: Lipid nanoparticles (LNPs)Transdermal patchesExtracellular vesicles (EVs)
Industry: Biotech

Partnerships

Mirai Creation InvestmentCollaborative development with companies and academia (specific partners not publicly listed)

Beyond the preview

Go deeper on NOVIGO Pharma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOVIGO Pharma Inc..

Explore the full profile